Company intelligence / Profile preview

inContAlert

Bayreuth / Trautskirchen, Bavaria/Bayern, Germanyincontalert.de ↗

Ownership: Private
Employees: ~13
Development stage: Preclinical

Overview

inContAlert has developed a patented wearable sensor that continuously monitors the filling level of the urinary bladder using electrical signals. Data are analyzed by AI algorithms and visualized via an app that alerts users before critical levels are reached. The solution aims to reduce reliance on catheters/diapers, prevent health complications from over-distension or unnecessary emptying, improve patient autonomy/QoL, optimize care workflows, and lower healthcare costs. Clinical validation studies are ongoing; CE mark approval targeted for early/mid 2024.

Therapeutic areas: PsychiatryNephrologyNeurology
Modalities: DeviceNon-pharmacological therapy (wearable sensor system)Digital health platform (app with AI/ML analytics)
Industry: Physiological Monitoring

Beyond the preview

Go deeper on inContAlert.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on inContAlert.

Explore the full profile